Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer

PURPOSE: This study was conducted to investigate whether a proton pump inhibitor (PPI) could enhance chemosensitivity via the inhibition of vacuolar-type H(+) ATPase (V-ATPase) in cervical cancer. MATERIALS AND METHODS: The expression of V-ATPase was evaluated in 351 formalin-fixed, paraffin-embedde...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Taejong, Jeon, Hye-Kyung, Hong, Ji Eun, Choi, Jung-Joo, Kim, Tae-Joong, Choi, Chel Hun, Bae, Duk-Soo, Kim, Byoung-Gie, Lee, Jeong-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512380/
https://www.ncbi.nlm.nih.gov/pubmed/27669706
http://dx.doi.org/10.4143/crt.2016.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512380/
https://www.ncbi.nlm.nih.gov/pubmed/27669706
http://dx.doi.org/10.4143/crt.2016.034

Ejemplares similares